Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03077737 · ClinicalTrials.gov registry record · NA
Reducing Tobacco Use Disparities Among Low-Income Adults
A NA study of Nicotine Dependence and Cigarette Smoking, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 190
- Enrollment target
- 1
- Study location
NCT03077737: Completed NA study of Nicotine Dependence and Cigarette Smoking, sponsored by Northwestern University.
NCT03077737 is a NA study of Nicotine Dependence and Cigarette Smoking that has completed, run by Northwestern University. The registered enrollment target is 190 participants, roughly in line with the 184-participant average among 67 other Nicotine Dependence trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03077737, a NA study of Nicotine Dependence and Cigarette Smoking, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
- 1
- Study location
Study Summary
Most smokers, especially those who are poor, do not receive smoking cessation treatment during their healthcare visits. This study is evaluating a novel population health management intervention for low-income smokers. Automated via an EHR system, which is bidirectionally linked with the Illinois Tobacco Quitline, the intervention comprises a mailed letter and text messaging designed to motivate low-income patients, most of whom are not ready to quit, to accept and use proactive quitline treatment. Increased access to free effective treatment via the integration of healthcare systems and state quitline services may be especially significant in its impact on low-income smokers who are underserved and who carry a much greater burden of tobacco-related disease.
Primary Outcome
The number of participants who accepted the quitline call and accepted treatment as defined by enrolling in treatment and completing the first counseling session. Participants who returned a quitline call, enrolled in treatment, and completed the first counseling session were also counted as having engaged in treatment.
Conditions Studied
Interventions
- BEHAVIORAL Enhanced usual care
- BEHAVIORAL Choose to Change
Study Locations (1)
Illinois
- Northwestern University Feingberg School of Medicine, Dept. of Preventive Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2017-04-21 |
| Est. Completion | 2018-08-31 |
| Phase | NA |
What the finished NCT03077737 record still lists
NCT03077737 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 184-participant average among 67 other Nicotine Dependence trials with a reported enrollment target.
The record links to 2 conditions, with Nicotine Dependence appearing as the primary indexed condition, and to 2 interventions - of which Enhanced usual care is the first listed.
NCT03077737 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03077737 about?
NCT03077737 is a clinical study titled "Reducing Tobacco Use Disparities Among Low-Income Adults". Most smokers, especially those who are poor, do not receive smoking cessation treatment during their healthcare visits. This study is evaluating a novel population health management intervention for low-income smokers. Automated via an EHR system, which is bidirectionally linked with the Illinois To...
What is the current status of trial NCT03077737?
This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2017-04-21. Estimated completion is 2018-08-31.
What conditions does trial NCT03077737 study?
This clinical trial studies the following conditions: Nicotine Dependence, Cigarette Smoking.
What interventions are being tested in trial NCT03077737?
The interventions under investigation include: Enhanced usual care (BEHAVIORAL), Choose to Change (BEHAVIORAL).
Who is sponsoring clinical trial NCT03077737?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03077737 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03077737's enrollment target sits among peer trials
190 18th of 67 higher than 50 of 67 other Nicotine Dependence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nicotine Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
RECRUITING · NA
-
NeuroControl of Nicotine Dependence
RECRUITING · NA
-
Abuse Liability and Appeal of Oral Nicotine Products
RECRUITING · NA
-
Effects of E-cigs vs Pouches on Cigarette Smoking and Addiction
RECRUITING · NA
-
Young Adult Tobacco/Nicotine and Cannabis Co-use
RECRUITING · NA
-
Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI